Ryan Johnson

Ryan Johnson is an associate in the Technology and Life Sciences groups at Goodwin. He represents emerging growth technology and life sciences companies, as well as venture capital funds and other private investors. Ryan advises clients at every stage of their lifecycle, including formation, corporate governance and securities law matters, equity and debt financings, mergers and acquisitions, and public offerings.

• PathologyWatch in its sale to Sonic Healthcare
• Coalition in its acquisition of Jumbo Privacy
• BG Holdings in its acquisition of Belong Gaming
• Lunchbox in its acquisition of NovaDine
• Lunchbox in its acquisition of Delish
• Chord Commerce in its financing by Eclipse Ventures and Foundation Capital
• Builder.ai in its financing by Qatar Investment Authority
• AllerGenis in its Regulation CF financing
• B Capital in its various investments in Triumvira Immunologics
• Yogi in its financing by Blueprint Equity

Prior to joining Goodwin, Ryan began his legal career as an Associate at Shearman & Sterling LLP in New York.

Ryan’s publications include:

• Author, “Supervisors Without Supervision: Colon, McKenna, and the Confusing State of Supervisory Liability in the Second Circuit,” Washington and Lee Law Review, March 2020